Option delistings effective March 24th include Aligos Therapeutics (ALGS), Allbirds (BIRD), Biotricity Inc (BTCY), DWTX Stock (DWTX), Dixie Group Inc (DXYN), Genetic Technologies Limited (ADR) (GENE), Galecto (GLTO), ESS Tech (GWH), Trevena Inc (TRVN), and iShares S&P Develpd ex US Prprty Indx Fd (WPS).
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGS:
- Aligos Therapeutics announces inducement grants under Nasdaq listing rule
- Biotech Alert: Searches spiking for these stocks today
- Aligos Therapeutics Faces Challenges in Developing Hepatitis B Treatments Amidst Industry Competition
- Aligos Therapeutics price target lowered to $70 from $75 at H.C. Wainwright
- Aligos Therapeutics Advances Pipeline Amid Financial Challenges
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue